BullFrog AI is a Maryland-based company with an artificial intelligence platform that can be used by biopharmaceutical companies in their clinical development programs. Its stated mission is to find the connection between therapies and patients and improve their lives.
The company's platform is called bfLEAP and can be used as a prediction tool for clinical trials. The platform operates in five steps: ingest the data, data exploration and cleansing, analyze fields and distributions, correlation analysis, and build models. bfLEAP is intended to be used with late-stage drug candidates and it analyzes clinical trial datasets to predict how patients will respond to the therapies. The technology can be used to discover novel drug targets, find niche patient populations where a drug candidate is likely to be more effective, and identify combinations of drugs likely to provide synergistic effects.
BullFrog AI and EastBanc Technologies Seek to Fast-Track Biopharma Clinical Development
May 7, 2020
BullFrog AI Secures $200K from TEDCO's Seed Fund | TEDCO
April 7, 2020
Bullfrogai - Annapolis, USA
BullFrogAI Wins $200K Tedco Investment
April 6, 2020